Concord Wealth Partners Bio Techne Corp Transaction History
Concord Wealth Partners
- $673 Million
- Q2 2025
A detailed history of Concord Wealth Partners transactions in Bio Techne Corp stock. As of the latest transaction made, Concord Wealth Partners holds 44 shares of TECH stock, worth $2,546. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44
Previous 34
29.41%
Holding current value
$2,546
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TECH
# of Institutions
617Shares Held
160MCall Options Held
90KPut Options Held
14.2K-
Vanguard Group Inc Valley Forge, PA18.5MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$867 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.4MShares$658 Million0.08% of portfolio
-
State Street Corp Boston, MA6.53MShares$378 Million0.02% of portfolio
-
Morgan Stanley New York, NY5.72MShares$331 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.27B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...